alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### *** E.O. 12866 Review

– Draft

– Do Not Cite, Quote or Release During Review ***



### Preamble Section VI Table V

**- 32**  **Update**
**Table VI**

**- 32.**  **Costs and Benefits of Proposed Standards for HD Pickups and Vans Under Alternative Assumptions** 

Sensitivity Case Fuel Savings (billion gallons) CO2

Reduction (MMT) Fuel

Savings ($billion) Social

Costs ($billion) Social

Benefits ($billion) Net

Social Benefits ($billion) 6 Month Payback (main) 7.8 94.1 15.9 5.5 23.5 18.0 0 Month Payback 8.9 107.7 18.3 5.8 27.0 21.3 12 Month Payback 7.4 87.2 15.2 5.6 21.9 16.3 18 Month Payback 5.5 65.8 11.7 4.9 16.8 11.9 24 Month Payback 4.5 52.7 9.2 4.4 13.3 8.9 AEO

-Low 8.1 94.7 11.5 5.1 17.8 12.7 AEO

-High 7.3 84.9 19.6 5.8 27.4 21.6 AEO

-Low, 0 Month Payback 9.3 109.1 13.3 5.6 20.6 15.1 AEO

-High, 24 Month Payback 2.8 32.4 7.2 2.9 10.2 7.3 50pct Owner/operatorBenefit 7.8 91.5 8.0 5.8 15.0 9.2 75pct Owner/operator Benefit 7.8 91.5 11.9 5.8 19.0 13.2 Low SCC 7.8 91.5 15.9 5.8 20.5 14.8 Low SCC, 0 Month Payback 8.9 104.7 18.3 6.1 23.6 17.5 High SCC 7.8 91.5 15.9 5.8 24.7 19.0 High SCC, 0 Month Payback 8.9 104.7 18.3 6.1 28.5 22.4 Very High SCC 7.8 91.5 15.9 5.8 29.5 23.8 Very High SCC, 0 Month Payback 8.9 104.7 18.3 6.1 34.0 27.9 05 Pct Rebound Effect 8.2 95.7 16.6 5.0 23.0 18.0 15 Pct Rebound Effect 7.5 87.2 15.2 6.5 22.9 16.4 20 Pct Rebound Effect 7.1 83.0 14.4 7.2 22.8 15.5 RPE

-Based Markup 7.6 90.1 16.0 7.6 22.9 15.4 Mass Fatality Coeff 05pct 7.8 91.5 15.9 4.4 23.0 18.5 Mass Fatality Coeff 95pct 7.8 91.5 15.9 7.1 23.0 15.8 NoSHEVs 7.2 84.3 14.6 8.0 21.1 13.1 NoSHEVs, 0 Month Payback 7.0 82.0 14.3 4.4 20.6 16.2 Lower Effectiveness 7.9 94.0 16.7 6.8 23.9 17.1 Higher Effectiveness 7.5 88.0 15.3 10.1 22.1 12.0 Lower Direct Costs 7.7 90.5 15.8 5.2 22.8 17.6 Higher Direct Costs 7.8 91.5 8.5 3.8 13.8 10.0 Wider Diesel Downsizing 8.9 104.7 9.9 4.0 15.9 11.9 07 Pct Discount Rate 9.0 96.3 15.3 7.2 22.7 15.5 07 Pct DR, 0 Month Payback 10.3 112.2 18.2 8.5 26.9 18.4 Allow Gas To Diesel 7.9 92.3 16.0 5.9 23.1 17.2 Allow Gas To Diesel, 0 Month Payback 7.3 85.8 15.1 6.9 21.7 14.8 Flat mix after 2016 8.4 99.8 17.6 7.4 25.4 17.9
[Federal Register Volume 89, Number 32 (Thursday, February 15, 2024)]
[Notices]
[Pages 11844-11845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03195]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C.,

[[Page 11845]]

as amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID New Innovators Awards (DP2 
Clinical Trial Not Allowed).
    Date: March 11-13, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Rockville, MD 
20852 (Video Assisted Meeting).
    Contact Person: Vanitha Sundaresa Raman, Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, MSC 9834, 
Rockville, MD 20852, 301-761-7949, <a href="/cdn-cgi/l/email-protection#6e180f00071a060f401c0f030f002e00070640090118"><span class="__cf_email__" data-cfemail="186e7976716c7079366a7975797658767170367f776e">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03195 Filed 2-14-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       2,748,812
<SECURITIES>                                         0
<RECEIVABLES>                                  635,826
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,384,638
<PP&E>                                     169,496,346
<DEPRECIATION>                           (164,158,568)
<TOTAL-ASSETS>                               8,722,416
<CURRENT-LIABILITIES>                          967,553
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   7,754,863
<TOTAL-LIABILITY-AND-EQUITY>                 8,722,416
<SALES>                                      8,521,418
<TOTAL-REVENUES>                             8,613,502
<CGS>                                        3,717,690
<TOTAL-COSTS>                                3,717,690
<OTHER-EXPENSES>                               544,760
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              4,351,052
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          4,351,052
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 4,351,052
<EPS-BASIC>                                      2,707
<EPS-DILUTED>                                    2,707


</TABLE>
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1634 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 1634

 To amend the Internal Revenue Code of 1986 to extend the financing of 
                             the Superfund.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 15, 2011

 Mr. Pallone (for himself and Mr. Blumenauer) introduced the following 
      bill; which was referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to extend the financing of 
                             the Superfund.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Superfund Polluter Pays Act''.

SEC. 2. EXTENSION OF SUPERFUND TAXES.

    (a) Excise Taxes.--Section 4611(e) of the Internal Revenue Code of 
1986 is amended to read as follows:
    ``(e) Application of Hazardous Substance Superfund Financing 
Rate.--The Hazardous Substance Superfund financing rate under this 
section shall apply after December 31, 1986, and before January 1, 
1996, and after the date of the enactment of this subsection and before 
January 1, 2019.''.
    (b) Corporate Environmental Income Tax.--Section 59A(e) of the 
Internal Revenue Code of 1986 is amended to read as follows:
    ``(e) Application of Tax.--The tax imposed by this section shall 
apply to taxable years beginning after December 31, 1986, and before 
January 1, 1996, and to taxable years beginning after the date of the 
enactment of this subsection and before January 1, 2019.''.
    (c) Technical Amendments.--
            (1) Section 4611(b) of the Internal Revenue Code of 1986 is 
        amended--
                    (A) by striking ``or exported from'' in paragraph 
                (1)(A),
                    (B) by striking ``or exportation'' in paragraph 
                (1)(B), and
                    (C) by striking ``and Exportation'' in the heading.
            (2) Section 4611(d)(3) of such Code is amended--
                    (A) by striking ``or exporting the crude oil, as 
                the case may be'' in the text and inserting ``the crude 
                oil'', and
                    (B) by striking ``or exports'' in the heading.
    (d) Effective Dates.--
            (1) Excise taxes.--The amendments made by subsections (a) 
        and (c) shall take effect on the date of the enactment of this 
        Act.
            (2) Income tax.--The amendment made by subsection (b) shall 
        apply to taxable years beginning after the date of the 
        enactment of this Act.
                                 <all>
```
**EXHIBIT 31.2****CERTIFICATIONS**I, Michael L. DeMarco, certify that:1. I have reviewed this annual report on Form 10-K of Peoples Educational Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officers and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: a) designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;  b) evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controlsand procedures, as of the end of the period covered by this report based on suchevaluation; and  c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and5. The registrant’s other certifying officers and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions): a) all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  b) any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.Date: August 17, 2007   /s/ Michael L. DeMarco Michael L. DeMarco,  Chief Financial Officer
[Federal Register Volume 89, Number 36 (Thursday, February 22, 2024)]
[Notices]
[Page 13353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03550]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of Support for Research 
Excellence--First Independent Research (SuRE-First) Award (R16).
    Date: April 4-5, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Lisa A. Dunbar, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
MSC 6200, Room 3AN18D, Bethesda, Maryland 20892, 301-594-2849, 
<a href="/cdn-cgi/l/email-protection#90f4e5fef2f1e2fcd0fdf1f9fcbefef9f8bef7ffe6"><span class="__cf_email__" data-cfemail="b2d6c7dcd0d3c0def2dfd3dbde9cdcdbda9cd5ddc4">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program No. 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated: February 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03550 Filed 2-21-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<ARTICLE>                                       7
<CIK>                                  0000727892
<NAME>                 IDS Life Insurance Company
<MULTIPLIER>                                 1000
<CURRENCY>                            U.S. DOLLAR
       
<S>                                   <C>
<FISCAL-YEAR-END>                     DEC-31-1997
<PERIOD-START>                        JAN-01-1997
<PERIOD-END>                          DEC-31-1997
<PERIOD-TYPE>                                YEAR
<EXCHANGE-RATE>                                 1
<DEBT-HELD-FOR-SALE>                     12876694
<DEBT-CARRYING-VALUE>                     9315450
<DEBT-MARKET-VALUE>                       9743410
<EQUITIES>                                   3361
<MORTGAGE>                                3618647
<REAL-ESTATE>                              102433
<TOTAL-INVEST>                           26628256
<CASH>                                      19686
<RECOVER-REINSURE>                            989
<DEFERRED-ACQUISITION>                    2479577
<TOTAL-ASSETS>                           52974124
<POLICY-LOSSES>                          26037036
<UNEARNED-PREMIUMS>                             0
<POLICY-OTHER>                                  0
<POLICY-HOLDER-FUNDS>                       68345
<NOTES-PAYABLE>                                 0
<COMMON>                                     3000
<PREFERRED-MANDATORY>                           0
<PREFERRED>                                     0
<OTHER-SE>                                2862816
<TOTAL-LIABILITY-AND-EQUITY>             52974124
<PREMIUMS>                                 206494
<INVESTMENT-INCOME>                       1988389
<INVESTMENT-GAINS>                            860
<OTHER-INCOME>                             682618
<BENEFITS>                                1598123
<UNDERWRITING-AMORTIZATION>                322731
<UNDERWRITING-OTHER>                       276596
<INCOME-PRETAX>                            680911
<INCOME-TAX>                               206664
<INCOME-CONTINUING>                        474247
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                               474247
<EPS-PRIMARY>                                   0
<EPS-DILUTED>                                   0
<RESERVE-OPEN>                              26387
<PROVISION-CURRENT>                        144098
<PROVISION-PRIOR>                               0
<PAYMENTS-CURRENT>                         143237
<PAYMENTS-PRIOR>                                0
<RESERVE-CLOSE>                             27248
<CUMULATIVE-DEFICIENCY>                         0
        

</TABLE>
**Exhibit 32
**Certification Pursuant to Rule 13a-14(b) or 15d-14(b) of the Securities and Exchange Act of 1934 and		Pursuant to Section 1350 of Chapter 63 of the Title 18 of the United States Code as adopted pursuant to Section 906		of the Sarbanes-Oxley Act of 2002**

The certification set forth below is being submitted in connection with theAnnual Report on Form 10-K for the year ended December 31, 2008 (the “Report”)for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of theSecurities Act of 1934 (the “Exchange Act”) and section 1350 of Chapter 63 ofTitle 18 of the United States Code 

Ann D. Murtlow, President and Chief Executive Officer and Kirk B. Michael,Vice President and Chief Financial Officer of IPALCO Enterprises, Inc.(“IPALCO”), each certifies that, to the best of his or her knowledge: 
- the Report fully complies with the requirements of Section 13(a) or	15(d) of the Exchange Act; and 
- the information contained in the Report fairly presents, in all material	respects, the financial condition and results of operations of IPALCO. 
      /s/ Ann D. Murtlow  /s/ Kirk B. Michael   Ann D. Murtlow  Kirk B. Michael   *President and Chief Executive Officer* *Vice President and Chief Financial Officer*  February 26, 2009  February 26, 2009       
A signed original of this written statement required by Section 906 has beenprovided to IPALCO and will be retained by IPALCO and furnished to theSecurities and Exchange Commission or its staff upon request.**
### ;--;T^/i£N TO F

Feb . 14 , 201 2 MS-QRWIO N Docke t Managemen t Facilit y U.S . Dept . o fTransportatio n -MiS'^ ' P i'U 5 Docke t No . FAA-2012-008 9 120 0 Ne wJerse yAve . S E Wes t Buildin g Gran d Floo r Roo m W-12014 0 Washington , D

C 2059 0 T o Who m I t Ma yConcern : I a m writin g i n suppor t o fSu n CountryAirline s havin g dockin g spac e a t Reaga n Nationa l Airport , i n orde rt o maintai n yea rroun d servic e betwee n Capita l Regio n Internationa l Airpor t i n Lansing , Michigan , an d Reaga n Nationa l Airport . Thi s rout e i s extremel yimportan t t o Greate rLansing' s economi cdevelopmen t efforts . Th e exemptio n tha t Su n Countryseek s wil l no t adversel yaffec t safety , sinc e th e airlin e has provide d saf e servic e o n th e rout e sinc e April , 2011 . Pleas e authoriz e additiona l slot s t o Su n Countryunde rth e exemptio n rule . Than k you . Sincerely ,

Yvonn e Seama n 1310 5 SchaveyRoad Suit e 10 5 DeWitt , M l 4882 0
I 

112TH CONGRESS 

1ST SESSION H. R. 1497 

To direct the Secretary of Defense to take whatever steps may be necessary 

to exhume and transfer the remains of certain deceased members of 

the Armed Forces buried in Tripoli, Libya, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 12, 2011 

Mr. ROGERS of Michigan (for himself and Mr. LOBIONDO) introduced the following bill; which was referred to the Committee on Veterans’ Affairs, 

and in addition to the Committee on Armed Services, for a period to be 

subsequently determined by the Speaker, in each case for consideration 

of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To direct the Secretary of Defense to take whatever steps 

may be necessary to exhume and transfer the remains 

of certain deceased members of the Armed Forces buried 

in Tripoli, Libya, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pwalker on DSKD5P82C1PROD with BILLS
2 

•HR 1497 IH

1 SECTION 1. EXHUMATION AND TRANSFER OF REMAINS OF 

2 DECEASED MEMBERS OF THE ARMED 

3 FORCES BURIED IN TRIPOLI, LIBYA. 

4 (a) IN GENERAL.—Notwithstanding any other provi5 sion of law, the Secretary of Defense shall take whatever 

6 steps may be necessary to— 

7 (1) exhume the remains of any deceased mem8 bers of the Armed Forces of the United States bur9 ied at a burial site described in subsection (b); 

10 (2) transfer such remains to an appropriate 

11 forensics laboratory to be identified; 

12 (3) in the case of any remains that are identi13 fied, transport the remains to a veterans cemetery 

14 located in proximity, as determined by the Secretary, 

15 to the closest living family member of the deceased 

16 individual or at another cemetery as determined by 

17 the Secretary; 

18 (4) for any member of the Armed Forces whose 

19 remains are identified, provide a military funeral 

20 and burial; and 

21 (5) in the case of any remains that are unable 

22 to be identified, transport the remains to Arlington 

23 National Cemetery for interment at the Tomb of the 

24 Unknowns. 

25 (b) BURIAL SITES DESCRIBED.—The burial sites de26 scribed in this subsection are the following: 


pwalker on DSKD5P82C1PROD with BILLS
3 

•HR 1497 IH

1 (1) The mass burial site containing the remains 

2 of five United States sailors located in Protestant 

3 Cemetery in Tripoli, Libya. 

4 (2) The mass burial site containing the remains 

5 of eight United States sailors located near the walls 

6 of the Tripoli Castle in Tripoli, Libya. 

Æ 


pwalker on DSKD5P82C1PROD with BILLS